Members of Congress say consumers often suffer when makers of brand-name drugs manipulate patents to stave off competition and keep prices high.
Tribe Joins Pharma at SCOTUS, Defending Lucrative Deal
Comment
Show comments
Hide Comments
Members of Congress say consumers often suffer when makers of brand-name drugs manipulate patents to stave off competition and keep prices high.
